Optimizing targets and therapeutics in high risk and refractory multiple myeloma

Researchers have to date focused on therapy aimed primarily at the cancer cells, but recently, however, scientists have realised that not enough attention was being paid to the impact of the bone marrow microenvironment on multiple myeloma. The microenvironment often provides a protective niche for the tumour and in many cases optimal conditions for growth. The concept of the OPTATIO (OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma) project is to develop tools to interfere with the cancer microenvironment and in this way improve the chances of therapy in the fight against multiple myeloma. Read more here.